IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -3.13% |
| 2024 | 9.01% |
| 2023 | 48.54% |
| 2022 | 150.81% |
| 2021 | -8.11% |
| 2020 | -19.51% |
| 2019 | 816.79% |
| 2018 | 20.18% |
| 2017 | 0.00% |
| 2016 | 0.00% |